Respiratory Organizations Tackle the Challenge of Reducing Delays in Diagnosing Complex Lung DiseasesAmerican College of Chest Physicians (CHEST), Chronic Fibrosing Interstitial Lung Diseases (ILD), Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Initiatives, Lung Disease, Nonprofit, R&D, RespiratoryThree Lakes Foundation and the American College of Chest Physicians (CHEST) recently announced their collaboration on a multiphase educational initiative aiming to reduce the time it takes to diagnose patients with Interstitial Lung Diseases (ILD). Read more April 18, 2022/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2022-04-18 18:09:182022-04-19 18:40:26Respiratory Organizations Tackle the Challenge of Reducing Delays in Diagnosing Complex Lung Diseases
